Parathyroid Allotransplant for Treatment of Hypoparathyroidism

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 15, 2026

Primary Completion Date

January 15, 2028

Study Completion Date

January 15, 2028

Conditions

HypoparathyroidismHypoparathyroidism PostproceduralHypoparathyroidism Post-surgical

Interventions

BIOLOGICAL

Parathyroid Allotransplant

Trial Locations (1)

University of California, San Francisco, San Francisco

All Listed Sponsors

lead

Peter Stock

OTHER

NCT06961071 - Parathyroid Allotransplant for Treatment of Hypoparathyroidism | Biotech Hunter | Biotech Hunter